Trial Profile
The Dutch STRIDER (Sildenafil TheRapy In Dismal Prognosis Early-onset Fetal Growth Restriction)
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 22 Jan 2024
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Fetal growth retardation
- Focus Therapeutic Use
- Acronyms STRIDER
- 01 Jan 2024 Results of a post-hoc secondary analysis assessing differences in neonatal outcomes when comparing different corticosteroid timing strategies published in the Acta Obstetricia et Gynecologica Scandinavica
- 01 Apr 2022 Results of a post hoc analysis assessed the neonatal pulmonary hypertension after severe early-onset fetal growth restriction published in the European Journal of Pediatrics
- 01 Aug 2018 The trial has been discontinued in Netherlands.